Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.
about
P1343
Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155Co-infections and Pathogenesis of KSHV-Associated MalignanciesKaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasionHsp90 inhibitors are efficacious against Kaposi Sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteinsLANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complexRole of heme oxygenase-1 in the pathogenesis and tumorigenicity of Kaposi's sarcoma-associated herpesvirusCooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma.Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis.Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.Increased tumorigenicity of cells carrying recombinant human herpesvirus 8.KSHV-induced notch components render endothelial and mural cell characteristics and cell survival.Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen.The MARCH family E3 ubiquitin ligase K5 alters monocyte metabolism and proliferation through receptor tyrosine kinase modulation.Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma.A systems biology approach identified different regulatory networks targeted by KSHV miR-K12-11 in B cells and endothelial cellsThe RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation.Viral profiling identifies multiple subtypes of Kaposi's sarcoma.Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infectionKSHV miRNAs decrease expression of lytic genes in latently infected PEL and endothelial cells by targeting host transcription factors.Molecular and cellular mechanisms of KSHV oncogenesis of Kaposi's sarcoma associated with HIV/AIDSExperimental selection of long-term intracellular mycobacteria.Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies.The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis.Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesisElevated cytokines, thrombin and PAI-1 in severe HCPS patients due to Sin Nombre virus.Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen reduces interleukin-8 expression in endothelial cells and impairs neutrophil chemotaxis by degrading nuclear p65.Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and Kaposi's sarcoma.Glutamate secretion and metabotropic glutamate receptor 1 expression during Kaposi's sarcoma-associated herpesvirus infection promotes cell proliferation.Latent KSHV infection increases the vascular permeability of human endothelial cells.Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells.Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHVPersistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.Molecular characterization of the rhesus rhadinovirus (RRV) ORF4 gene and the RRV complement control protein it encodesKaposi's Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-β Signaling.Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance.Kaposi's sarcoma and its associated herpesvirus.KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor.G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity.
P2860
Q24681400-011E0BF9-CA7F-48FF-9DF5-6261A90F2F6CQ26766493-F370E02D-0DB5-4B95-B7DB-60666FC6CD89Q28388436-62437293-8FFA-4811-A324-89C993CCBC4CQ28472867-55FEC856-5D67-4BDE-B62E-48AFFF82D869Q28485399-B97C2128-AD28-4D74-8EF0-922A6B725AFBQ28540872-80A4EBA7-DF69-484E-8163-FC9282D588C0Q28829309-6D4C9D30-24F5-450C-9DDB-0BF10C4DAA1DQ30418735-18DBF7D0-B8C4-467C-9EA5-6E2D9A004582Q33301012-FC9D4A1C-3550-4198-B546-5C87235D0F96Q33432690-F574B236-74EA-4B06-B6AA-5CB1C9D6260CQ33585787-1B73CC78-6F11-4E95-81BC-8187BAF97A12Q33627013-21654D2F-0D4F-4684-9DD4-DB79B016A663Q33820704-767E8C25-61F7-4C70-8FF0-BC7D6F09CD79Q33872257-2940DBB5-9187-41EF-AC87-932944DEB4C3Q34022457-078CAF97-A5CD-4739-84A2-6F49C0AB7294Q34100180-827B07D6-33EE-467C-BB98-28B11004ECAEQ34130213-4F7E8ECB-BDF9-4FA9-BAC0-1D6D2C59A44DQ34237734-2DD999F8-78A8-476A-8612-2C5E33E9D9B8Q34257818-B0EA0614-CECB-4F21-B94D-4536F42D4EC9Q34423454-4100DD75-AECE-46B6-805D-E2A0FB7AE7D4Q34663095-29FC5A18-8AD5-44D1-B2F5-4892F465F922Q34819470-03FCB920-92B7-4F76-B046-51A175A9F4C9Q34845533-DCE74E4B-E660-48D2-B7AA-79E30F3C5B57Q35066362-C92DFA28-6C8E-496E-8D35-B56EDCEBB206Q35124404-22F33F0E-93E3-47A4-A899-10988C2CD1E4Q35159993-7D0AE7E9-1688-44CF-997D-70B6FCDD7795Q35192868-E8E98E6D-DDC9-4B5F-B9F6-3578A2885316Q35235757-2EEB01A0-8B1A-4660-9B2D-E266E33D78B8Q35315503-617A842D-6DA6-427D-990B-F1ADE9F2CD9FQ35553639-2237EA6D-F1C3-4BC4-AC2A-C7994327D58AQ35689577-F58B355B-8F08-48F7-A7F3-C9D9C6298519Q35780222-A82BBED4-56E8-4124-B716-128147B55304Q35784707-637B4D28-9781-40CD-B4A4-0C5D84D111A3Q35785343-39EE7B34-546D-4037-8F31-A618AB7CA495Q35834474-64851C94-01DE-48B5-9362-AFC179B86520Q35861265-D5E5DF33-FF73-4572-B240-E8467ED3C7EBQ36098894-2A4100E4-3405-45AA-B478-B3CBFDE64B17Q36487309-EF6FF128-516D-4457-A55A-76906E0136F4Q36591375-4724C46E-70BF-41CB-BC21-74C3D3620A27Q36663052-0C90A94E-FC68-464B-B866-63850F6654AE
P2860
Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Long-term-infected telomerase- ...... latency in vitro and in vivo.
@en
type
label
Long-term-infected telomerase- ...... latency in vitro and in vivo.
@en
prefLabel
Long-term-infected telomerase- ...... latency in vitro and in vivo.
@en
P2093
P2860
P1433
P1476
Long-term-infected telomerase- ...... latency in vitro and in vivo.
@en
P2093
Dirk P Dittmer
Farnaz D Fakhari
Feng-Qi An
Hope Merlene Folarin
Justin Roth
Keith R McCrae
Nicole Compitello
Stanton L Gerson
P2860
P304
P356
10.1128/JVI.80.10.4833-4846.2006
P407
P4510
P50
P577
2006-05-01T00:00:00Z